Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

NovoCure Ltd Director's Dealing 2017

Nov 14, 2017

31949_dirs_2017-11-14_61a86c90-2a4e-4a4d-a5b5-7ea428289382.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Novocure Ltd (NVCR)
CIK: 0001645113
Period of Report: 2017-11-13

Reporting Person: Palti Yoram (Director, Chief Technology Officer)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2017-11-13 Ordinary Shares S 30000 $17.129 Disposed 1431054 Indirect

Footnotes

F1: On November 13, 2017, pursuant to a Rule 10b5-1 trading plan adopted by Bennett Limited, Bennett Limited sold 30,000 shares in multiple trades at prices ranging from $16.925 to $17.35. The price reported above reflects the weighted average sale price. Bennett Limited hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected.

F2: Professor Palti shares voting and investment power for the shares held by Bennett Limited.